Norepinephrine: the next therapeutics frontier for Parkinson's disease
<p>Abstract</p> <p>Tissue concentrations of norepinephrine (NE) are markedly decreased in various regions of the Parkinson's disease (PD) brain. As in the substantia nigra pars compacta, neuronal dropout and Lewy bodies are prominent changes affecting the locus coeruleus, whic...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | http://www.translationalneurodegeneration.com/content/1/1/4 |